Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IKT Inhibikase Therapeutics, Inc.

未开盘 07-25 16:00:00 EDT

1.60

-0.04

-2.44%

盘后1.57

-0.03-1.88%

16:00 EDT

最高1.73	最低1.51	成交量7,520
今开1.52	昨收1.64	日振幅13.41%
总市值1,155万	流通市值915.41万	总股本721.61万
成交额1.18万	换手率0.13%	流通股本572.13万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IKT","market":"US","secType":"STK","nameCN":"Inhibikase Therapeutics, Inc.","latestPrice":1.6,"timestamp":1721937600000,"preClose":1.64,"halted":0,"volume":7520,"hourTrading":{"tag":"盘后","latestPrice":1.57,"preClose":1.6,"latestTime":"16:00 EDT","volume":35,"amount":54.95,"timestamp":1721937601675},"delay":0,"floatShares":5721313,"shares":7216145,"eps":-3.326521,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.04,"latestTime":"07-25 16:00:00 EDT","open":1.52,"high":1.73,"low":1.51,"amount":11791.733744,"amplitude":0.134146,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.326521,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721980800000},"adr":0,"listingDate":1608699600000,"adjPreClose":1.64,"postHourTrading":{"tag":"盘后","latestPrice":1.57,"preClose":1.6,"latestTime":"16:00 EDT","volume":35,"amount":54.95,"timestamp":1721937601675},"volumeRatio":0.20217},"requestUrl":"/m/hq/s/IKT/tweets","defaultTab":"tweets","newsList":[{"id":"2454877447","title":"Inhibikase Therapeutics, Inc.盘中异动 急速下挫6.71%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454877447","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454877447?lang=zh_cn&edition=full","pubTime":"2024-07-25 22:38","pubTimestamp":1721918300,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日22时38分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速跳水6.71%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072522382096820565&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072522382096820565&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2453889423","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘快速上涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453889423","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453889423?lang=zh_cn&edition=full","pubTime":"2024-07-24 22:58","pubTimestamp":1721833132,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日22时58分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速拉升5.77%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724225852aefb420d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724225852aefb420d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2453799885","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘快速下挫6.17%报1.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453799885","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453799885?lang=zh_cn&edition=full","pubTime":"2024-07-22 22:25","pubTimestamp":1721658328,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日22时25分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅下挫6.17%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722222528aefacb9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722222528aefacb9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2452510472","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘快速上涨5.48%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452510472","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452510472?lang=zh_cn&edition=full","pubTime":"2024-07-19 22:19","pubTimestamp":1721398793,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日22时19分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅上涨5.48%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719221953af9331b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719221953af9331b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2452305764","title":"Inhibikase Therapeutics, Inc.盘中异动 下午盘急速上涨6.71%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452305764","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452305764?lang=zh_cn&edition=full","pubTime":"2024-07-19 01:48","pubTimestamp":1721324938,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日01时48分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速上涨6.71%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.68%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719014858af930197&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719014858af930197&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2452502311","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌6.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452502311","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452502311?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:05","pubTimestamp":1721225102,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日22时05分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速跳水6.39%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.79%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071722050295ceff72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071722050295ceff72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2451135659","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘急速下跌8.72%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451135659","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451135659?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:10","pubTimestamp":1721139012,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日22时10分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速跳水8.72%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716221012af929a87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716221012af929a87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2451621147","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451621147","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451621147?lang=zh_cn&edition=full","pubTime":"2024-07-15 22:58","pubTimestamp":1721055494,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日22时58分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅拉升5.15%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715225814941f7136&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715225814941f7136&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2450777539","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘急速上涨7.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450777539","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450777539?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:23","pubTimestamp":1720794189,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时23分，Inhibikase Therapeutics, Inc.股票出现异动，股价大幅拉升7.35%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.43%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712222309af921ed3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712222309af921ed3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2450369584","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘快速拉升5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450369584","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450369584?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:09","pubTimestamp":1720706968,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时09分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速上涨5.34%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711220928aef93eaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711220928aef93eaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2450303700","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大涨12.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450303700","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450303700?lang=zh_cn&edition=full","pubTime":"2024-07-09 00:16","pubTimestamp":1720455365,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日00时16分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速拉升12.93%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709001605941f4f91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709001605941f4f91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2449296098","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅拉升5.17%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449296098","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449296098?lang=zh_cn&edition=full","pubTime":"2024-07-05 22:52","pubTimestamp":1720191130,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日22时52分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速拉升5.17%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.22%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705225210af90cbe5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705225210af90cbe5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2448910958","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅跳水6.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448910958","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448910958?lang=zh_cn&edition=full","pubTime":"2024-07-02 00:16","pubTimestamp":1719850598,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日00时16分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速下挫6.61%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702001638941f2caa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702001638941f2caa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2446685927","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘急速拉升5.58%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446685927","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446685927?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:53","pubTimestamp":1719582812,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时53分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速上涨5.58%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628215332941f2535&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628215332941f2535&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2446311465","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446311465","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446311465?lang=zh_cn&edition=full","pubTime":"2024-06-27 01:41","pubTimestamp":1719423662,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日01时41分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速下挫5.45%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.37%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627014102941f171d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627014102941f171d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2446886954","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅下跌6.43%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446886954","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446886954?lang=zh_cn&edition=full","pubTime":"2024-06-25 03:40","pubTimestamp":1719258003,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日03时40分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅下跌6.43%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.63%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625034003af8ef17f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625034003af8ef17f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2445240104","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅下挫5.12%报1.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445240104","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445240104?lang=zh_cn&edition=full","pubTime":"2024-06-21 02:10","pubTimestamp":1718907027,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日02时10分，Inhibikase Therapeutics, Inc.股票出现异动，股价大幅下跌5.12%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621021027aef5de4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621021027aef5de4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2444430450","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌6.29%报1.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444430450","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444430450?lang=zh_cn&edition=full","pubTime":"2024-06-19 00:08","pubTimestamp":1718726892,"startTime":"0","endTime":"0","summary":"北京时间2024年06月19日00时08分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅下挫6.29%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619000812af8e1609&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619000812af8e1609&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2444319558","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘大幅上涨9.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444319558","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444319558?lang=zh_cn&edition=full","pubTime":"2024-06-17 22:45","pubTimestamp":1718635514,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日22时45分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速拉升9.93%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617224514941eefd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617224514941eefd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2443960403","title":"Inhibikase Therapeutics, Inc.盘中异动 急速下跌9.02%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443960403","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443960403?lang=zh_cn&edition=full","pubTime":"2024-06-15 03:27","pubTimestamp":1718393244,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日03时27分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速跳水9.02%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615032725941eeb92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615032725941eeb92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inhibikase.com","stockEarnings":[{"period":"1week","weight":0.0959},{"period":"1month","weight":0.1548},{"period":"3month","weight":-0.0643},{"period":"6month","weight":-0.4595},{"period":"1year","weight":-0.3676},{"period":"ytd","weight":0.2598}],"compareEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.0118},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.1046},{"period":"1year","weight":0.182},{"period":"ytd","weight":0.1328}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inhibikase Therapeutics, Inc.于2010年6月3日注册为特拉华州公司。该公司是一家临床阶段制药公司，致力于开发针对帕金森氏病或PD以及大脑内外发生的相关疾病的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.425952},{"month":2,"riseRate":0.5,"avgChangeRate":-0.118451},{"month":3,"riseRate":0.25,"avgChangeRate":0.045803},{"month":4,"riseRate":0,"avgChangeRate":-0.217435},{"month":5,"riseRate":0.75,"avgChangeRate":0.088455},{"month":6,"riseRate":0,"avgChangeRate":-0.283409},{"month":7,"riseRate":0.5,"avgChangeRate":-0.006105},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.009751},{"month":9,"riseRate":0,"avgChangeRate":-0.186153},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.155622},{"month":11,"riseRate":0.666667,"avgChangeRate":-0.050918},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.028053}],"exchange":"NASDAQ","name":"Inhibikase Therapeutics, Inc.","nameEN":"Inhibikase Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inhibikase Therapeutics, Inc.(IKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inhibikase Therapeutics, Inc.,IKT,Inhibikase Therapeutics, Inc.股票,Inhibikase Therapeutics, Inc.股票老虎,Inhibikase Therapeutics, Inc.股票老虎国际,Inhibikase Therapeutics, Inc.行情,Inhibikase Therapeutics, Inc.股票行情,Inhibikase Therapeutics, Inc.股价,Inhibikase Therapeutics, Inc.股市,Inhibikase Therapeutics, Inc.股票价格,Inhibikase Therapeutics, Inc.股票交易,Inhibikase Therapeutics, Inc.股票购买,Inhibikase Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inhibikase Therapeutics, Inc.(IKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}